Moberg Pharma AB (OMX: MOB) and Allderma today announce that the launch of Terclara® (MOB-015) is ongoing in Norway. The launch marks an important step in both companies' commercial strategy and ...
During the year, the company launched Cetzine (Cetirizine; anti-histamine), Zimig (terbinafine ... and Rosuvastatin tablets were launchec in Cardiology under the brand names Lilo and Rosutec ...
Boston.com on MSN12d
F.D.A. Approves Drug to Treat Pain Without Opioid EffectsThe drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Your brand's ability and willingness to solve pain points for current and potential customers can make or break your company's existence and relevance in the industry. To help brand leaders remain ...
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...
Apple’s iPads have long been the gold standard in the tablet industry, consistently outpacing competitors in performance, display quality, software optimization, and overall user experience.
Samsung Frame Pro Shuts Down The Art TV Haters! Tomsguide is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.
As we enter 2025, it is clearer than ever that in the back half of this decade, brand building and audience engagement will be rooted in the creation of brand-funded content and entertainment.
Apple iPad (10th Generation): with A14 Bionic chip, 27.69 cm (10.9″) Liquid Retina Display, 64GB, Wi-Fi 6, 12MP front/12MP Back Camera, Touch ID, All-Day Battery Life – Blue View Details ...
The drug, suzetrigine, received the FDA's official stamp of approval Thursday to be sold as a 50-milligram prescription pill ...
the Paonta Sahib police today seized counterfeit wrappers of popular drug brands from the premises of a printing press. The printing press operator failed to produce authorisation letters or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results